Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 11/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL808879 | 0.94 | ALDH1A1 (0.39) | FDPSGGPS1ALDH1A1ESR1ESR2 | |
| SCHEMBL309728 | 0.92 | FDPS (0.44) | FDPSGGPS1TSHR | |
| Ammonia Solution, Strong SCHEMBL597182 | 0.91 | FDPS (0.37) | FDPSGGPS1ALDH1A1ESR1ESR2 | |
| SCHEMBL5872627 | 0.91 | FDPS (0.37) | FDPSGGPS1ALDH1A1ESR1ESR2 | |
| Phosphine SCHEMBL27893442 | 0.91 | FDPS (0.37) | FDPSGGPS1ALDH1A1ESR1ESR2 | |
| SCHEMBL3190341 | 0.91 | FDPS (0.37) | FDPSGGPS1ALDH1A1 | |
| SCHEMBL2826148 | 0.91 | ALDH1A1 (0.37) | FDPSGGPS1ALDH1A1LMNA | |
| SCHEMBL25260775 | 0.89 | FDPS (0.46) | FDPSGGPS1TSHR | |
| SCHEMBL10783590 | 0.89 | FDPS (0.46) | FDPSGGPS1TSHR | |
| SCHEMBL14776690 | 0.89 | FDPS (0.46) | FDPSGGPS1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1037 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119002096-A | Method for manufacturing contact lens | 望隼科技股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| EP-3976362-B1 | METHOD FOR MAKING OPAQUE COLORED SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2023-06-07 | — | — | EP | claimed |
| US-11584097-B2 | Method for making opaque colored silicone hydrogel contact lenses | ALCON INC. (CH) | 2023-02-21 | — | — | US | claimed |
| EP-3976362-A1 | METHOD FOR MAKING OPAQUE COLORED SILICONE HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2022-04-06 | — | — | EP | claimed |
| WO-2020240440-A1 | METHOD FOR MAKING OPAQUE COLORED SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2020-12-03 | — | — | WO | claimed |
| US-20200376787-A1 | METHOD FOR MAKING OPAQUE COLORED SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2020-12-03 | — | — | US | claimed |
| US-9688838-B1 | Diisononyl terephthalate plasticizer and its use as well as process for producing the same | NAN YA PLASTICS CORPORATION (TW) | 2017-06-27 | — | — | US | claimed |
| US-20160201093-A1 | Process for the Bioconversion of C3-C13 Alkanes to C3-C13 Primary Alcohols | BASF SE (DE) | 2016-07-14 | — | — | US | claimed |
| EP-3027760-A1 | PROCESS FOR THE BIOCONVERSION OF C3-C13 ALKANES TO C3-C 13 PRIMARY ALCOHOLS | BASF SE (DE) | 2016-06-08 | — | — | EP | claimed |
| WO-2015014644-A1 | PROCESS FOR THE BIOCONVERSION OF C3-C13 ALKANES TO C3-C 13 PRIMARY ALCOHOLS | BASF SE (DE) | 2015-02-05 | — | — | WO | claimed |
| US-20090146330-A1 | METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2009-06-11 | — | — | US | claimed |
| CN-1150211-C | Siloxanes hydrogel polymers | �Ʒ� | 2004-05-19 | — | — | CN | claimed |
| EP-0908744-B1 | Silicone hydrogel polymers | JOHNSON & JOHNSON VISION PROD (US) | 2002-12-18 | — | — | EP | claimed |
| US-6020445-A | Silicone hydrogel polymers | JOHNSON & JOHNSON VISION PRODUCTS, INC. (US) | 2000-02-01 | — | — | US | claimed |
| CN-1218816-A | Siloxanes hydrogel polymers | JOHNSON & JOHNSON VISION PROD (US) | 1999-06-09 | — | — | CN | claimed |
| EP-0908744-A1 | Silicone hydrogel polymers | JOHNSON & JOHNSON VISION PRODUCTS, INC. (US) | 1999-04-14 | — | — | EP | claimed |
| EP-0324980-B1 | Norbornene formulations with longer pot lives and lower molding temperatures | GOODRICH CO B F (US) | 1995-03-29 | — | — | EP | claimed |
| EP-0324979-B1 | Norbornene formulations with longer pot lives | GOODRICH CO B F (US) | 1994-03-23 | — | — | EP | claimed |
| EP-0324979-A2 | Norbornene formulations with longer pot lives | THE B.F. GOODRICH COMPANY (US) | 1989-07-26 | — | — | EP | claimed |
| EP-0324980-A2 | Norbornene formulations with longer pot lives and lower molding temperatures | THE B.F. GOODRICH COMPANY (US) | 1989-07-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11584097-B2 | Method for making opaque colored silicone hydrogel contact lenses | COIL, CRYAB, CRYAA | FDPS 3030/4885GGPS1 2930/4885ALDH1A1 3383/4885 |
| US-20200376787-A1 | METHOD FOR MAKING OPAQUE COLORED SILICONE HYDROGEL CONTACT LENSES | COIL, CRYAB, CRYAA | FDPS 3030/4885GGPS1 2930/4885ALDH1A1 3383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.